Alexander Hladky

Experience

• 

  Mallinckrodt Pharmaceuticals

  Vice President of Global Procurement

  Jan 2019 - Dec 2025

  Mallinckrodt Pharmaceuticals is a leading, multibillion-dollar specialty pharmaceutical company with a core focus on meeting the needs of patients and their families. With a history that spans 150 years, Mallinckrodt is dedicated to delivering innovative solutions and therapies to address unmet patient needs, with a strong emphasis on quality, integrity, and service. The company's diverse portfolio of specialty pharmaceuticals caters to a wide range of health conditions, including autoimmune and rare diseases, immunotherapy, and neonatal respiratory critical care, among others. Mallinckrodt is committed to being an innovation-driven company, investing in research and development to improve outcomes for patients with serious and critical conditions. The company's core strengths lie in its unique approach to solving complex challenges with distinctive solutions, reflecting their commitment to patient-centered care and collaborative innovation. With a strong focus on their values of Patient-Centric, Integrity, Innovative, and Collaborative, Mallinckrodt Pharmaceuticals continues to shape the future of specialty pharmaceuticals, guided by a rich heritage of quality and service. Discover the culture and career opportunities at Mallinckrodt by visiting their Careers site.

  • Managed global procurement team and associated operations proactively.
  • Optimized relationships strategically with key suppliers and stakeholders to support achievement of operational excellence and customer focused value.
  • Implemented innovative digital capabilities and analytics.
  • Re-organized procurement to establish matrixed, highly effective organization integrated with business planning and cost leadership.
  • Established sourcing center of excellence to support generic and brand competitive differentiation.
  • Directed vendor base during two Chapter 11 bankruptcies to ensure no interruption of supply and business operations.
• 

  Mallinckrodt Pharmaceuticals

  Vice President, Global Procurement

  Jan 2019 - Dec 2025

  • Managed global procurement team and associated operations proactively.
  • Optimized relationships strategically with key suppliers and stakeholders to support achievement of operational excellence and customer focused value.
  • Implemented innovative digital capabilities and analytics.
  • Re-organized procurement to establish matrixed, highly effective organization integrated with business planning and cost leadership.
  • Established sourcing center of excellence to support generic and brand competitive differentiation.
  • Directed vendor base during two Chapter 11 bankruptcies to ensure no interruption of supply and business operations.
• 

  BIOLOGOS

  President

  Jan 2016 - Dec 2019

  A Trusted Biologics Partner Since 1976 Biologos is a full-service manufacturer of standard and custom cell culture media, buffers, reagents, and sera specializing in quick turn product formulation, manufacturing and distribution. As our customers pursue the global advancement of health and wellness, we built our company on a foundation of continuous improvement of our processes, equipment and expertise. Our Mission To exceed customer expectations through the production of superior standard and custom products, driven by our commitment to customer satisfaction, continuous innovation, and excellence in manufacturing.

  • Grew and managed Biologos business, which specialized in sales, production, and distribution of custom sterile liquids (sera, cell culture media, and reagents) to Animal Health Pharmaceutical, Tissue Bank, and Xenograft markets.
  • Re-organized and upgraded 40-year, founder owned company.
  • Implemented auditable financial system and Salesforce-based commercial operation.
  • Performed implementation of ERP-based product management and S&OP processes.
  • Established supply chain to standardize warehousing and distribution process
• 

  Phibro Animal Health

  Senior Vice President | Sourcing | Strategy | Quality

  Jan 2011 - Dec 2016

  Phibro Animal Health is a leading global provider of animal health and nutrition products and services. Headquartered in Teaneck, New Jersey, United States, the company has a history dating back to 1949 when it was founded as a division of the Metals and Minerals Corporation. It became an independent company in 2014 and is publicly traded on the NASDAQ Stock Exchange under the ticker symbol PAHC. Phibro Animal Health offers a wide range of products and services that enhance animal health, productivity, and well-being. Their product portfolio includes vaccines, nutritional specialty products, medicated feed additives, and genetic improvement programs. These products cater to various species including poultry, swine, cattle, aquaculture, and companion animals. Additionally, the company provides technical support and consulting services to customers across the globe. With a global presence, Phibro Animal Health operates through a network of subsidiaries, joint ventures, and partnerships. Some of its noteworthy subsidiaries include Phibro Animal Health Asia Pacific, Phibro Animal Health Europe, and Phibro Animal Health Brazil. These subsidiaries help the company expand its reach and serve customers in different regions. In terms of market position, Phibro Animal Health is a strong player in the global animal health market. It competes with other major companies such as Zoetis, Elanco Animal Health, and Merck Animal Health. The company's global sales have shown steady growth in recent years, and it continues to expand its customer base and market share. Phibro Animal Health has achieved several significant milestones and events. In 2016, they acquired MVP Laboratories, a leader in veterinary autogenous biologics. This acquisition expanded the company's product portfolio and strengthened its presence in the swine and turkey markets. Additionally, the company has also focused on research and development to introduce innovative products that address the changing needs of the animal health industry. Currently, Phibro Animal Health continues to operate as a key player in the animal health and nutrition market. The company focuses on providing high-quality products and services, contributing to the overall well-being and productivity of animals globally.

  • Responsible for global product management, distribution, and sourcing.
  • Managed relationships with critical business partners.
  • Directed product quality for global network of internal and CMO production and distribution facilities.
  • Established and managed strategic sourcing model for finished products, APIs, and critical raw materials to ensure competitive price, uninterrupted supply, and product quality, with extensive experience sourcing in Asia.
  • Optimized sourcing and supply chain processes and vendor performance by utilizing supply agreements, service agreements and vendor evaluation tools to manage supplier quality, performance, and price.
  • Led Phibro's response to identify alternate locations, complete validations, and ensure uninterrupted supply of product to customers, after loss of 80% of production capacity due to facility collapse.
• 

  Phibro Animal Health

  Senior Vice President, Sourcing, Strategy and Quality

  Jan 2011 - Dec 2016

  • Responsible for global product management, distribution, and sourcing.
  • Managed relationships with critical business partners.
  • Directed product quality for global network of internal and CMO production and distribution facilities.
  • Established and managed strategic sourcing model for finished products, APIs, and critical raw materials to ensure competitive price, uninterrupted supply, and product quality, with extensive experience sourcing in Asia.
  • Optimized sourcing and supply chain processes and vendor performance by utilizing supply agreements, service agreements and vendor evaluation tools to manage supplier quality, performance, and price.
  • Led Phibro's response to identify alternate locations, complete validations, and ensure uninterrupted supply of product to customers, after loss of 80% of production capacity due to facility collapse.
• 

  Pfizer

  Vice President | Supply Chain | Quality

  Jan 2002 - Dec 2011

  Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. We make medicines and vaccines that help people when they are sick and prevent them from getting sick in the first place, as well as some of the world’s best-known consumer healthcare brands. Every day, our colleagues work in developed and emerging markets to treat, cure and eradicate life-threatening conditions and challenge some of the most feared diseases of our time. Pfizer also collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, visit www.pfizer.com.

  • Directed global supply chain (including API sourcing), compliance, and quality for division that manufactured (six U.S. and two Chinese facilities) and distributed animal health pharmaceutical products globally, in over 80 countries, as integral member of Alpharma animal health leadership team.
  • Restructured global supply chain operations to right size resources, improve performance, and save over $20 million annually.
  • Established robust internal manufacturing and CMO sourcing process to support flexible and responsive global network that supplied registered material to over 80 countries.

• Alpharma, Inc.

  Vice President, Global Quality and Supply Chain

  Jan 2002 - Dec 2011

  Alpharma, Inc. is a company.

  • Directed global supply chain (including API sourcing), compliance, and quality for division that manufactured (six U.S. and two Chinese facilities) and distributed animal health pharmaceutical products globally, in over 80 countries, as integral member of Alpharma animal health leadership team.
  • Restructured global supply chain operations to right size resources, improve performance, and save over $20 million annually.
  • Established robust internal manufacturing and CMO sourcing process to support flexible and responsive global network that supplied registered material to over 80 countries.
• 

  Ecolab

  Quality | Environmental | Health | Safety Manager

  Feb 1999 - Jul 2002

  A trusted partner for millions of customers, Ecolab (NYSE:ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life.

  • Responsible for all technical regulatory activties (FDA, EPA, OSHA, DOT/Hazmat, etc.) for Ecolab's Atlantic Region and Canada.
  • Participated in the succesful design, construction and start-up of a 250,000 sq. ft chemical manufacturing and distribution facility in West Virginia.
• 

  Ecolab

  Quality and Environmental, Health and Safety Manager

  Feb 1999 - Jul 2002

  • Responsible for all technical regulatory activties (FDA, EPA, OSHA, DOT/Hazmat, etc.) for Ecolab's Atlantic Region and Canada.
  • Participated in the succesful design, construction and start-up of a 250,000 sq. ft chemical manufacturing and distribution facility in West Virginia.
• 

  Tyco

  Senior Manager of Environmental | Health | Safety

  Jan 1997 - Dec 1999

  As the global leader in smart, healthy and sustainable buildings, our mission is to reimagine the performance of buildings to serve people, places & the planet.

  • Managed the integration of EHS compliance systems with ISO 9000 quality system to provide seamless transition of EHS management into daily operations.
  • Achieved below industry average OSHA incidence rates.
• 

  Tyco International Ltd.

  Senior Manager, Environmental, Health and Safety (EHS)

  Jan 1997 - Dec 1999

  • Managed the integration of EHS compliance systems with ISO 9000 quality system to provide seamless transition of EHS management into daily operations.
  • Achieved below industry average OSHA incidence rates.
• 

  Kearfott Corporation

  Manager of Environmental | Health | Safety

  Aug 1993 - Feb 1997

  Kearfott is a leader in the design, manufacture, and support of guidance, navigation, and motion-control products for the aerospace, defense, energy exploration, and unmanned system markets. The company is dedicated to providing quality, reliability, and cutting-edge technology to customers worldwide to meet their sea, land, air, and space navigation and guidance requirements. For over 100 years, Kearfott has demonstrated a commitment to delivering the best, most innovative technology for guidance, navigation, and motion control products. Its products guide spacecraft and strategic missiles, navigate autonomously undersea, provide navigation and fire control for ground vehicles, and control motion aboard both military and commercial aircraft. Kearfott is a subsidiary of Astronautics Corporation of America, a global leader in the design, development, and manufacture of avionics equipment and systems for the commercial and military aerospace industry.

  • Proactively managed all safety, health and environmental activities of the corporation. Including four manufacturing locations in New Jersey, North Carolina & Mexico.
  • Aggressively managed 4 state mandated (NJ ISRA) investigations/remediations and 1 CERCLA case to save millions in remediation costs.
  • All facilities achieved OSHA recordable rates of less than one during tenure.
  • Achieved Certified Industrial Hygienist (CIH) and Certified Safety Professional (CSP) designations during tenure.
• 

  Kearfott Guidance and Navigation

  Manager, Environmental, Health and Safety

  Aug 1993 - Feb 1997

  • Proactively managed all safety, health and environmental activities of the corporation. Including four manufacturing locations in New Jersey, North Carolina & Mexico.
  • Aggressively managed 4 state mandated (NJ ISRA) investigations/remediations and 1 CERCLA case to save millions in remediation costs.
  • All facilities achieved OSHA recordable rates of less than one during tenure.
  • Achieved Certified Industrial Hygienist (CIH) and Certified Safety Professional (CSP) designations during tenure.